These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37387937)

  • 1. Retracted: Exploring the Effect of Dapagliflozin on Alcoholic Kidney Injury and Renal Interstitial Fibrosis in Rats Based on TIMP-1/MMP-24 Pathway.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9830542. PubMed ID: 37387937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the Effect of Dapagliflozin on Alcoholic Kidney Injury and Renal Interstitial Fibrosis in Rats Based on TIMP-1/MMP-24 Pathway.
    Wu Y; Song P; Yuan X; Li D
    Evid Based Complement Alternat Med; 2021; 2021():6538189. PubMed ID: 34721639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial fibrosis in mice with overload proteinuria: deficiency of TIMP-1 is not protective.
    Eddy AA; Kim H; López-Guisa J; Oda T; Soloway PD
    Kidney Int; 2000 Aug; 58(2):618-28. PubMed ID: 10916085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fosinopril and valsartan intervention in gene expression of Klotho, MMP-9, TIMP-1, and PAI-1 in the kidney of spontaneously hypertensive rats.
    Cheng X; Zhou Q; Lin S; Wu R
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Oct; 35(10):1048-56. PubMed ID: 21051829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
    Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of MMP-2 and TIMP-1 in renal tissue of patients with chronic active antibody-mediated renal graft rejection.
    Yan Q; Sui W; Wang B; Zou H; Zou G; Luo H
    Diagn Pathol; 2012 Oct; 7():141. PubMed ID: 23057632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation into the effect and mechanism of dapagliflozin against renal interstitial fibrosis based on transcriptome and network pharmacology.
    Liu Y; Wang Y; Chen S; Bai L; Xie X; Zhang L; Wang X
    Int Immunopharmacol; 2022 Nov; 112():109195. PubMed ID: 36070627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Losartan alleviates renal fibrosis by down-regulating HIF-1α and up-regulating MMP-9/TIMP-1 in rats with 5/6 nephrectomy.
    Fu W; Wang Y; Jin Z; Wang H; Cheng W; Zhou H; Yin P; Peng W
    Ren Fail; 2012; 34(10):1297-304. PubMed ID: 23006043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of MMP-2 and TIMP-1 in renal tissues of patients with chronic active antibody-mediated renal graft rejection].
    Wang BY; Yan Q; Zou HQ; Sui WG; Zuo GM; Liang GR; Luo H; Xie SY; Chen HZ; Xie SP
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):2048-51. PubMed ID: 22200710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of matrix accumulation and glomerulosclerosis in spontaneously hypertensive rats.
    Camp TM; Smiley LM; Hayden MR; Tyagi SC
    J Hypertens; 2003 Sep; 21(9):1719-27. PubMed ID: 12923405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamate ionotropic receptor NMDA type subunit 1: A novel potential protein target of dapagliflozin against renal interstitial fibrosis.
    Liu Y; Wang Y; Chen S; Bai L; Li F; Wu Y; Zhang L; Wang X
    Eur J Pharmacol; 2023 Mar; 943():175556. PubMed ID: 36736528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of tissue inhibitor of metalloproteases-1 (TIMP-1) and procollagen-N-peptidase in hypertension-induced renal damage.
    Hultström M; Leh S; Skogstrand T; Iversen BM
    Nephrol Dial Transplant; 2008 Mar; 23(3):896-903. PubMed ID: 17977875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of immunoexpression of matrix metalloproteinases in renal chronic allograft injury.
    Wagrowska-Danilewicz M; Danilewicz M
    Pol J Pathol; 2009; 60(2):88-93. PubMed ID: 19886183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue inhibitor of metalloproteinase-1 exacerbated renal interstitial fibrosis through enhancing inflammation.
    Cai G; Zhang X; Hong Q; Shao F; Shang X; Fu B; Feng Z; Lin H; Wang J; Shi S; Yin Z; Chen X
    Nephrol Dial Transplant; 2008 Jun; 23(6):1861-75. PubMed ID: 18326884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TIMP-1 deficiency does not attenuate interstitial fibrosis in obstructive nephropathy.
    Kim H; Oda T; López-Guisa J; Wing D; Edwards DR; Soloway PD; Eddy AA
    J Am Soc Nephrol; 2001 Apr; 12(4):736-748. PubMed ID: 11274235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retracted: Dapagliflozin Inhibits Ventricular Remodeling in Heart Failure Rats by Activating Autophagy through AMPK/mTOR Pathway.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9850245. PubMed ID: 38077859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte growth factor modulates matrix metalloproteinases and plasminogen activator/plasmin proteolytic pathways in progressive renal interstitial fibrosis.
    Gong R; Rifai A; Tolbert EM; Centracchio JN; Dworkin LD
    J Am Soc Nephrol; 2003 Dec; 14(12):3047-60. PubMed ID: 14638904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of exercise training on renal interstitial fibrosis and renin-angiotensin system in rats with chronic renal failure.
    Yamakoshi S; Nakamura T; Mori N; Suda C; Kohzuki M; Ito O
    J Hypertens; 2021 Jan; 39(1):143-152. PubMed ID: 32833922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in matrix metalloproteinases during the evolution of interstitial renal fibrosis in a rat experimental model.
    González-Avila G; Iturria C; Vadillo-Ortega F; Ovalle C; Montaño M
    Pathobiology; 1998; 66(5):196-204. PubMed ID: 9732233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retracted: Dapagliflozin Improves Diabetic Cardiomyopathy by Modulating the Akt/mTOR Signaling Pathway.
    International BR
    Biomed Res Int; 2023; 2023():9765065. PubMed ID: 37388370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.